These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 2536102)

  • 1. Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology.
    Newell CK; Martin S; Sendele D; Mercadal CM; Rouse BT
    J Virol; 1989 Feb; 63(2):769-75. PubMed ID: 2536102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets or asialo GM1+ cells.
    Staats HF; Oakes JE; Lausch RN
    J Virol; 1991 Nov; 65(11):6008-14. PubMed ID: 1920624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes.
    Doymaz MZ; Rouse BT
    Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2165-73. PubMed ID: 1351475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of CD4+ and CD8+ T-lymphocyte depletion on the induction and expression of herpes simplex stromal keratitis.
    Newell CK; Sendele D; Rouse BT
    Reg Immunol; 1989; 2(6):366-9. PubMed ID: 2518571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology.
    Hendricks RL; Tumpey TM
    Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):1929-39. PubMed ID: 2170289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA; Knipe DM
    Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cellular immune tolerance to HSV-1 antigens on the immunopathology of HSV-1 keratitis.
    Hendricks RL; Epstein RJ; Tumpey T
    Invest Ophthalmol Vis Sci; 1989 Jan; 30(1):105-15. PubMed ID: 2536358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An experimental study of immune mediating action of T-lymphocyte subsets on recurrent herpetic stromal keratitis].
    Xia L; Shu H; Gao D
    Zhonghua Yan Ke Za Zhi; 2000 Jan; 36(1):27-31. PubMed ID: 11853578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent requirement for CD4+ T cells in primary anti-herpes simplex virus cytotoxic T-lymphocyte induction can be overcome by optimal antigen presentation.
    Mercadal CM; Martin S; Rouse BT
    Viral Immunol; 1991; 4(3):177-86. PubMed ID: 1687350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent regeneration of T lymphocytes and susceptibility to HSV-1 corneal stromal disease.
    Hendricks RL; Tumpey TM
    Curr Eye Res; 1991; 10 Suppl():47-53. PubMed ID: 1677883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas.
    Hendricks RL; Janowicz M; Tumpey TM
    J Immunol; 1992 Apr; 148(8):2522-9. PubMed ID: 1313845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system.
    Nash AA; Jayasuriya A; Phelan J; Cobbold SP; Waldmann H; Prospero T
    J Gen Virol; 1987 Mar; 68 ( Pt 3)():825-33. PubMed ID: 2950204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CD4+ cells in sustaining lymphocyte proliferation during lymphocytic choriomeningitis virus infection.
    Kasaian MT; Leite-Morris KA; Biron CA
    J Immunol; 1991 Mar; 146(6):1955-63. PubMed ID: 1672337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus--induced destructive corneal disease.
    Foster CS
    Eye (Lond); 1989; 3 ( Pt 2)():194-203. PubMed ID: 2559859
    [No Abstract]   [Full Text] [Related]  

  • 15. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
    Smith PM; Wolcott RM; Chervenak R; Jennings SR
    Virology; 1994 Jul; 202(1):76-88. PubMed ID: 7912023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-mitogenic anti-CD3F(ab')2 monoclonal antibody: a novel approach to control herpetic stromal keratitis.
    Sarangi PP; Kim B; Rouse BT
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5425-33. PubMed ID: 18689698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8 T cells mediate transient herpes stromal keratitis in CD4-deficient mice.
    Lepisto AJ; Frank GM; Xu M; Stuart PM; Hendricks RL
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3400-9. PubMed ID: 16877409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis.
    Russell RG; Nasisse MP; Larsen HS; Rouse BT
    Invest Ophthalmol Vis Sci; 1984 Aug; 25(8):938-44. PubMed ID: 6611324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amniotic membrane transplantation induces apoptosis in T lymphocytes in murine corneas with experimental herpetic stromal keratitis.
    Bauer D; Wasmuth S; Hennig M; Baehler H; Steuhl KP; Heiligenhaus A
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3188-98. PubMed ID: 19255156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.